Skip to content

C7A.026 ICD-10-CM Code: Malignant carcinoid tumor of the rectum

C7A.026 maps to CMS-HCC V28 21. A source-labeled RAF reference is available. Confirm the documented diagnosis and applicable coding requirements. MEAT criteria · RAF Calculator · HCC coding software

ICD-10-CM Code View

HCC Buddy Code Card

Digital ICD-10 code-book layout with official code detail, always-visible risk models, Code Trumping, and Buddy coding guidance.

Code lookupC7A.026

FY 2026 Apr update / Neoplasms (C00-D49) / Malignant neuroendocrine tumors (C7A)

C7A.026

Billable / SpecificICD-10-CMOfficial ICD-10-CMCodebook guidance

Malignant carcinoid tumor of the rectum

A rare cancer that develops in hormone-producing cells of the rectum, the final section of the large intestine before the anus.

Buddy the Bee presenting code insight

Buddy Insight

Malignant carcinoid tumor of the rectum is the most common colorectal carcinoid tumor, often discovered incidentally during routine screening colonoscopy.

CMS-HCC V28

HCC 21

Coefficient HCC 21: 0.671 (Community Non-Dual Aged (CNA))

CMS-HCC V24

Historical

Historical

Not used for CY2026 payment

ACA/HHS

HCC 012

Code-level coefficient reference

ESRD/PACE

HCC 12

Code-level coefficient reference

RXHCC

HCC 22

Code-level coefficient reference

Inclusion Terms

Official

No inclusion terms are included in this display for C7A.026. Check the code and parent instructions in the Code Book.

Excludes 2

Official
  • malignant pancreatic islet cell tumors (C25.4)Inherited from C7A
  • Merkel cell carcinoma (C4A.-)Inherited from C7A

Includes

Official

No Includes notes are included in this display for C7A.026. Check the code and parent instructions in the Code Book.

Excludes 1

Official

No Excludes 1 notes are included in this display for C7A.026. Check the code and parent instructions in the Code Book.

Code First

Official

No Code First sequencing instructions are included in this display for C7A.026. Check the code and parent instructions in the Code Book.

Use Additional

Official
  • code to identify any associated endocrine syndrome, such as:Inherited from C7A
  • carcinoid syndrome (E34.00)Inherited from C7A

Code Also

Official
  • any associated multiple endocrine neoplasia [MEN] syndromes (E31.2-)Inherited from C7A

Buddy Documentation Tip

HCC Buddy guidance
Pathological confirmation of neuroendocrine tumor with malignant features
Tumor size — the most important prognostic factor (< 1 cm vs. 1-2 cm vs. > 2 cm)
Depth of invasion — submucosal versus muscularis propria or deeper
Ki-67 index and mitotic rate for WHO grading

MEAT Support

HCC Buddy guidance
Pathological confirmation of neuroendocrine tumor with malignant features
Tumor size — the most important prognostic factor (< 1 cm vs. 1-2 cm vs. > 2 cm)
Depth of invasion — submucosal versus muscularis propria or deeper
Ki-67 index and mitotic rate for WHO grading

Audit Caution

HCC Buddy guidance
Coding a benign, well-differentiated rectal neuroendocrine tumor (<1 cm, no invasion) as malignant without pathological evidence of malignant behavior
Confusing rectal adenocarcinoma with rectal carcinoid — they require completely different code categories
Not distinguishing rectal from sigmoid location at the rectosigmoid junction
Failing to document tumor size, which is the single most important prognostic factor for rectal carcinoids

Common Mistakes

HCC Buddy guidance
C20 — Primary malignant neoplasm of rectum; adenocarcinoma of rectum uses C20
C7A.025 — Malignant carcinoid tumor of sigmoid colon; rectosigmoid junction tumors need precise localization
D3A.026 — Benign carcinoid tumor of rectum; small, well-differentiated rectal carcinoids may qualify as benign
D12.8 — Benign neoplasm of rectum; rectal polyps are different from carcinoid tumors

Current with CMS: FY2026 ICD-10-CM Apr 1 update (effective Apr 1 – Sep 30, 2026) · CMS-HCC V28, 100% phased in for payment year 2026. FY2027 code set already staged for October 1, 2026. How HCC Buddy stays current →

Is C7A.026 an HCC code?

Yes. C7A.026 (Malignant carcinoid tumor of the rectum) maps to HCC 21, Lymphoma and Other Cancers under the CMS-HCC V28 risk adjustment model, with a source-labeled community non-dual aged reference coefficient of 0.671. Source-labeled code-level coefficients are references, not member totals. Actual contribution depends on complete member context, hierarchy and cleanup rules, interactions, and model year. HCC Buddy's RAF Calculator supports CMS-HCC V28 PY2026 and shows no score unless every required source and calculation check passes. It is billable for payment year 2026.

Coder answer: C7A.026 is billable and maps to V28 HCC 21, Lymphoma and Other Cancers. Open it in the Code Book for the tabular path, RAF, and MEAT checklist.

Code
C7A.026
Description
Malignant carcinoid tumor of the rectum
HCC (V28)
HCC 21 — Lymphoma and Other Cancers
RAF reference coefficient
0.671
Billable
Yes
Payment year
2026

HCC Category Mapping

V28HCC 21, Lymphoma and Other Cancers
0.671
ESRDHCC 12, Breast/Prostate/and Other Cancers and Tumors
Not separately weighted
RxHCCHCC 22, Prostate, Breast, Bladder, and Other Cancers and Tumors
Not separately weighted

These are source-labeled model coefficients, not member totals. A category may still be removed by hierarchy or model cleanup rules. Weights are not directly comparable across models: CMS-HCC V28 and V24 use Community, Non-Dual, Aged; ESRD uses the dialysis continuing-enrollee model; RxHCC is the Part D continuing-enrollee, non-low-income, aged weight (a larger scale than CMS-HCC). ACA/HHS has no single weight — it varies by metal level. Actual per-patient RAF contribution depends on member context, hierarchy and cleanup rules, interactions, and the model year used by the payer. V28 is the CMS-HCC model phased in over payment years 2024–2026; V24 remains available for historical review.

Work C7A.026 in the Code Book — tabular path, V28 RAF reference, and MEAT checklist →

MEAT review for C7A.026

For C7A.026, confirm that the documentation supports the diagnosis and meets the applicable coding, encounter, program and payer requirements. MEAT (Monitor, Evaluate, Assess, or Treat) is a review mnemonic, not a universal CMS coding rule.

  • MMonitor: signs, symptoms, disease progression, or lab trending documented in the note
  • EEvaluate: test results, medication response, or physical findings reviewed by the provider
  • AAssess: explicit mention in the assessment or plan with acknowledgment of status
  • TTreat: medication, referral, procedure, therapy, or counseling tied to the diagnosis

Coder workflow notes

Get the V28 mapping + MEAT cheat sheet

One printable reference: check representative V28 mappings and the documentation reminders your note needs. Free, no card.

Free PDF. No card. Unsubscribe anytime.

What This Code Means

C7A.026 is the ICD-10-CM diagnosis code for malignant carcinoid tumor of the rectum. A rare cancer that develops in hormone-producing cells of the rectum, the final section of the large intestine before the anus. C7A.026 sits in the ICD-10-CM chapter for neoplasms (c00-d49), within the section covering malignant neuroendocrine tumors (c7a).

Under the CMS-HCC V28 risk adjustment model, C7A.026 maps to Lymphoma and Other Cancers (HCC 21) with a source-labeled community, non-dual, aged reference coefficient of 0.671. No V24 mapping is shown for C7A.026; use the applicable model and payment year when reviewing the V28 mapping. For CY2026 non-PACE Medicare Advantage, CMS uses 100% of the 2024 CMS-HCC model (V28). PACE uses a separate model blend. Source-labeled code-level coefficients are references, not member totals. Actual contribution depends on complete member context, hierarchy and cleanup rules, interactions, and model year. HCC Buddy's RAF Calculator supports CMS-HCC V28 PY2026 and shows no score unless every required source and calculation check passes.

Rectal carcinoid tumors are often discovered during routine screening colonoscopy. For C7A.026, confirm that the documentation supports the diagnosis and meets the applicable coding, encounter, program and payer requirements. MEAT (Monitor, Evaluate, Assess, or Treat) is a review mnemonic, not a universal CMS coding rule. When documentation is ambiguous, coders should issue a provider query rather than assume the highest-specificity variant.

HCC Buddy maintains structured V28 and V24 mapping, source-labeled coefficient references, and MEAT documentation criteria for C7A.026 sourced directly from the CMS-HCC risk adjustment model files and the CMS ICD-10-CM code set.

Coding Tips

  • Rectal carcinoid tumors are often discovered during routine screening colonoscopy
  • Ensure documentation clarifies whether the tumor is in the rectum versus the sigmoid colon, as treatment approaches differ

Clinical Significance

Malignant carcinoid tumor of the rectum is the most common colorectal carcinoid tumor, often discovered incidentally during routine screening colonoscopy. Rectal carcinoids are hindgut tumors that rarely cause carcinoid syndrome. Most are small (<1 cm), confined to the submucosa, and carry an excellent prognosis. However, larger tumors (>2 cm) with invasion beyond the muscularis propria have significant metastatic potential.

Documentation Requirements

  • Pathological confirmation of neuroendocrine tumor with malignant features
  • Tumor size — the most important prognostic factor (< 1 cm vs. 1-2 cm vs. > 2 cm)
  • Depth of invasion — submucosal versus muscularis propria or deeper
  • Ki-67 index and mitotic rate for WHO grading
  • Endoscopic ultrasound assessment of invasion depth if available
  • Whether treated by endoscopic mucosal resection versus surgical resection

Commonly Confused Codes

  • C20: Primary malignant neoplasm of rectum; adenocarcinoma of rectum uses C20
  • C7A.025: Malignant carcinoid tumor of sigmoid colon; rectosigmoid junction tumors need precise localization
  • D3A.026: Benign carcinoid tumor of rectum; small, well-differentiated rectal carcinoids may qualify as benign
  • D12.8: Benign neoplasm of rectum; rectal polyps are different from carcinoid tumors

Child Codes

Code Hierarchy

Also searched as

  • C7A 026
  • C7A026

For C7A.026, confirm that the documentation supports the diagnosis and meets the applicable coding, encounter, program and payer requirements. MEAT (Monitor, Evaluate, Assess, or Treat) is a review mnemonic, not a universal CMS coding rule.

C7A.026 maps to CMS-HCC V28 category 21, Lymphoma and Other Cancers. See the ICD-10 to HCC mapping hub for how the V28 crosswalk works. The mapping identifies a payment HCC category for C7A.026. Review its source-labeled HCC coefficient above, check the RAF Calculator with complete member context for CMS-HCC V28 PY2026, and confirm the documentation the chart needs before the code is submitted. HCC Buddy shows no RAF score unless every required source and calculation check passes.

Work C7A.026 in HCC Buddy

Open C7A.026 in the Code Book for the full Index-to-Tabular path, MEAT checklist, and V28 HCC mapping, or in the Encoder to code from a keyword search. Pro includes 7 days to try everything, no card required.